| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 1,052 | 1,160 | 1,206 | 1,116 | 1,028 | 1,108 | 1,083 | 1,018 | 920 | 928 | 1,077 | 1,042 | 1,010 | 1,015 | 1,132 | 1,048 | 880 | 760 | 705 | 807 | 720 | 2,077 | 730 | 865 | 640 | 861 | 866 | 856 | 669 | 652 | 736 | 701 | 710 | 658 | 777 | 709 | 754 | 769 | 818 | 729 |
| Expenses | 943 | 973 | 1,031 | 1,001 | 945 | 1,016 | 964 | 995 | 1,028 | 1,309 | 1,001 | 959 | 1,024 | 1,003 | 1,058 | 1,064 | 827 | 726 | 670 | 656 | 674 | 1,298 | 697 | 706 | 698 | 739 | 765 | 742 | 871 | 611 | 831 | 657 | 771 | 642 | 681 | 664 | 803 | 648 | 699 | 593 |
| EBITDA | 109 | 187 | 175 | 116 | 83 | 92 | 119 | 23 | -108 | -381 | 76 | 84 | -15 | 12 | 74 | -16 | 53 | 34 | 35 | 151 | 47 | 779 | 33 | 159 | -58 | 122 | 101 | 114 | -202 | 41 | -95 | 44 | -61 | 16 | 96 | 45 | -49 | 121 | 119 | 136 |
| Operating Profit % | 13 % | 15 % | 16 % | 7 % | 6 % | 7 % | 9 % | 0 % | -19 % | -47 % | 2 % | 5 % | -1 % | 0 % | 6 % | -2 % | 4 % | -0 % | 2 % | 12 % | 2 % | -117 % | 2 % | 8 % | -10 % | 14 % | 11 % | 13 % | -33 % | -3 % | -22 % | 6 % | -14 % | 0 % | 10 % | 5 % | -15 % | 12 % | 14 % | 18 % |
| Depreciation | 34 | 35 | 35 | 36 | 37 | 36 | 37 | 38 | 37 | 37 | 36 | 38 | 38 | 39 | 40 | 41 | 45 | 55 | 53 | 56 | 61 | 56 | 57 | 68 | 65 | 64 | 61 | 62 | 59 | 64 | 65 | 66 | 56 | 55 | 55 | 55 | 58 | 54 | 55 | 55 |
| Interest | 14 | 24 | 30 | 32 | 43 | 49 | 56 | 61 | 59 | 61 | 68 | 62 | 65 | 73 | 65 | 64 | 64 | 71 | 65 | 79 | 61 | 74 | 61 | 60 | 55 | 64 | 69 | 80 | 86 | 73 | 70 | 83 | 76 | 79 | 76 | 77 | 73 | 73 | 73 | 60 |
| Profit Before Tax | 60 | 128 | 110 | 48 | 4 | 7 | 26 | -76 | -204 | -480 | -28 | -16 | -118 | -100 | -32 | -121 | -55 | -92 | -82 | 16 | -75 | 649 | -85 | 31 | -178 | -6 | -29 | -28 | -347 | -96 | -230 | -105 | -193 | -118 | -35 | -87 | -180 | -6 | -9 | 21 |
| Tax | 27 | 30 | 12 | -22 | 17 | -9 | 1 | -16 | 3 | -17 | -19 | 27 | 35 | -5 | -1 | -44 | -41 | -55 | 12 | -3 | -144 | -111 | -88 | -1 | -71 | 1 | -66 | -30 | -36 | -21 | -23 | -3 | 44 | 18 | 38 | -1 | -3 | 10 | 7 | 1 |
| Net Profit | 33 | 98 | 98 | 69 | -13 | 17 | 25 | -60 | -207 | -463 | -9 | -43 | -153 | -95 | -31 | -77 | -14 | -37 | -94 | 19 | 69 | 760 | 3 | 32 | -107 | -7 | 37 | 2 | -311 | -75 | -207 | -102 | -237 | -136 | -73 | -86 | -177 | -16 | -16 | 20 |
| EPS in ₹ | 3.10 | 8.36 | 8.37 | 6.52 | -0.49 | 1.44 | 2.25 | -4.88 | -15.81 | -37.06 | -0.80 | -3.69 | -13.97 | -7.79 | -2.06 | -6.42 | -2.62 | -4.06 | -7.42 | 0.87 | 4.36 | 68.64 | 0.32 | 1.38 | -8.38 | -1.15 | 2.79 | -0.61 | -21.20 | -4.64 | -13.15 | -6.62 | -14.37 | -9.28 | -5.37 | -5.75 | -11.64 | -0.95 | -1.47 | 0.91 |
Wockhardt
1,426.60
-51.35
(-3.47%)
Market Cap
24,012.60 Cr
EPS
-32.05
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
1,679.90
52 Week Low
490.15
PB Ratio
5.28
Debt to Equity
0.68
Sector
Pharmaceuticals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,764.75 | 4,28,233.30 | 35.92 | 49,887.20 | 12.06 | 9,648 | 13.77 | 61.58 | |
| 5,840.65 | 1,56,910.50 | 74.97 | 8,184.00 | 0.89 | 1,600 | 64.53 | 55.23 | |
| 1,511.20 | 1,23,084.40 | 24.45 | 26,520.70 | 14.17 | 4,155 | 47.38 | 60.28 | |
| 3,245.05 | 1,10,720.70 | 58.75 | 10,785.70 | 11.59 | 1,656 | 13.54 | 61.68 | |
| 1,177.90 | 1,00,988.70 | 18.34 | 28,905.40 | 12.36 | 5,578 | 1.69 | 51.86 | |
| 2,398.05 | 97,867.10 | 48.47 | 10,615.60 | 19.57 | 1,942 | -16.38 | 56.07 | |
| 2,068.75 | 96,711.60 | 32.93 | 20,141.50 | 19.94 | 1,936 | 38.82 | 54.50 | |
| 907.35 | 92,945.80 | 20.14 | 19,831.50 | 13.82 | 3,831 | 29.92 | 48.54 | |
| 1,194.95 | 70,253.80 | 19.68 | 29,559.20 | 17.55 | 3,169 | -10.04 | 61.05 | |
| 31,101.85 | 66,026.50 | 49.49 | 6,097.20 | 10.80 | 1,201 | 16.01 | 61.04 |
Growth Rate
Revenue Growth
3.89 %
Net Income Growth
-23.99 %
Cash Flow Change
43.14 %
ROE
-24.00 %
ROCE
-68.73 %
EBITDA Margin (Avg.)
-47.39 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 6,939 | 8,121 | 9,022 | 8,162 | 7,844 | 8,179 | 7,774 | 8,243 | 7,683 | 7,649 |
| Fixed Assets | 2,123 | 2,809 | 2,773 | 2,888 | 3,058 | 3,502 | 3,343 | 3,462 | 3,042 | 2,881 |
| Current Assets | 3,522 | 3,952 | 4,535 | 3,380 | 2,815 | 2,430 | 2,425 | 2,589 | 2,208 | 2,184 |
| Capital Work in Progress | 1,007 | 1,036 | 1,244 | 1,433 | 1,446 | 1,585 | 1,379 | 1,342 | 1,539 | 1,722 |
| Investments | 339 | 0 | 563 | 214 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 3,470 | 4,276 | 4,443 | 3,628 | 3,341 | 3,092 | 3,052 | 3,439 | 3,102 | 3,046 |
| Total Liabilities | 6,939 | 8,121 | 9,022 | 8,162 | 7,844 | 8,179 | 7,774 | 8,243 | 7,683 | 7,649 |
| Current Liabilities | 1,773 | 1,842 | 1,979 | 2,692 | 2,864 | 3,497 | 3,121 | 3,207 | 3,435 | 2,791 |
| Non Current Liabilities | 1,307 | 2,039 | 3,324 | 2,272 | 1,976 | 1,624 | 894 | 834 | 586 | 1,196 |
| Total Equity | 3,859 | 4,241 | 3,719 | 3,198 | 3,005 | 3,058 | 3,759 | 4,202 | 3,662 | 3,662 |
| Reserve & Surplus | 3,362 | 3,720 | 3,281 | 2,797 | 2,620 | 2,616 | 3,321 | 3,777 | 3,282 | 3,282 |
| Share Capital | 354 | 55 | 55 | 55 | 55 | 55 | 55 | 72 | 72 | 77 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 57 | 46 | 301 | -66 | -500 | -178 | 13 | 138 | -280 | 415 |
| Investing Activities | -222 | -106 | -684 | 635 | 93 | -147 | 1,471 | -204 | -118 | -138 |
| Operating Activities | 355 | -42 | -270 | 68 | 183 | 649 | -287 | 413 | 153 | 219 |
| Financing Activities | -76 | 193 | 1,255 | -770 | -777 | -680 | -1,171 | -71 | -315 | 334 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Nov 2024 | Dec 2024 |
| Promoter | 72.12 % | 69.68 % | 68.04 % | 67.13 % | 67.13 % | 65.75 % | 63.83 % | 60.36 % | 59.31 % | 58.40 % | 55.14 % | 54.93 % | 51.60 % | 51.99 % | 51.99 % | 49.09 % | 49.09 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 3.02 % | 0.00 % | 5.49 % | 5.93 % | 6.70 % | 6.62 % | 6.54 % |
| DIIs | 0.02 % | 0.02 % | 0.02 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.23 % | 0.22 % | 0.19 % | 0.22 % | 0.10 % | 4.83 % | 4.45 % | 5.09 % | 9.88 % | 9.82 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.02 % | 0.02 % | 0.02 % |
| Public / Retail | 21.41 % | 23.02 % | 25.24 % | 25.99 % | 24.56 % | 25.97 % | 27.42 % | 30.26 % | 31.45 % | 32.19 % | 32.89 % | 32.94 % | 29.94 % | 30.18 % | 29.02 % | 27.45 % | 27.49 % |
| Others | 6.46 % | 7.27 % | 6.69 % | 6.85 % | 8.28 % | 8.26 % | 8.72 % | 9.15 % | 9.02 % | 9.21 % | 8.72 % | 12.03 % | 8.13 % | 7.43 % | 7.19 % | 6.95 % | 7.04 % |
| No of Share Holders | 0 | 0 | 1,25,128 | 1,44,845 | 1,61,625 | 1,65,270 | 1,66,122 | 1,80,170 | 1,80,630 | 1,78,915 | 1,72,989 | 1,61,813 | 1,46,376 | 1,40,391 | 1,38,142 | 1,43,876 | 1,42,710 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 1.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Integrated Filing (Financial)
Statement On Deviation Or Variation Of Funds Raised Through Qualified Institutions Placements For The Quarter Ended 31St December 2024
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Board Meeting Outcome for Outcome Of The Board Meeting
Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Statement On Deviation Or Variation Of Funds Raised Through Qualified Institutions Placement For The Quarter Ended 30Th June, 2024 Confirming That There Has Been No Deviation In The Utilization Of Issue Proceeds.
Please Find Enclosed Herewith The Monitoring Agency Report Towards Utilization Of Proceeds Of Qualified Institutions Placement ('QIP') For The Quarter Ended September 30, 2024, Issued By CRISIL Ratings Limited.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024
Announcement under Regulation 30 (LODR)-Allotment
Board Meeting Outcome for Outcome Of The Meeting Of The Capital Raising Committee
Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited
Board Meeting Outcome for Outcome Of The Meeting Of The Capital Raising Committee For Qualified Institutions Placement Of Equity Shares Of Face Value Of ? 5 Each (The 'Equity Shares') To Qualified Institutional Buyers ('QIB').
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Investor Presentation
Reply To BSE''s Email Dated 16Th October, 2024 Relating To Volume Movement
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Clarification sought from Wockhardt Ltd
Disclosure under Regulation 30A of LODR
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Disclosure under Regulation 30A of LODR
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Change in Management
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Closure of Trading Window
Press Release -'Dr. Habil Khorakiwala Bestowed Lifetime Achievement Award By Integrated Health And Wellbeing Council In Dubai'.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Submission Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Technical Indicators
RSI(14)
Neutral 55.10
ATR(14)
Volatile 68.45
STOCH(9,6)
Overbought 87.50
STOCH RSI(14)
Neutral 79.14
MACD(12,26)
Bullish 26.18
ADX(14)
Weak Trend 22.96
UO(9)
Bearish 58.45
ROC(12)
Uptrend But Slowing Down 7.26
WillR(14)
Neutral -35.58
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
